Any changes observed are likely secondary to the metabolic and weight-related effects of the medication rather than a direct pharmacological action on the reproductive system
If taste changes significantly impair nutrition or quality of life despite management strategies, your healthcare provider may consider dose reduction, temporary treatment interruption, or switching to an alternative medication
At 48 weeks, average weight loss reached about 24% at the 12 mg dose among the strongest results reported for this class of medication
D.CumminsP
UHC coverage overview UnitedHealthcare is one of the largest health insurance providers in Virginia, covering millions of members across employer-sponsored, individual, Medicare, and Medicaid plans
For more information on GLP1R agonists and their impact on perioperative care, check out Anesthesia Updates on the NYSORA Anesthesia Assistant App